Digital Treatment for Osteoarthritis Superior to Traditional Routine Care

Joint AcademyFirst-line treatment of knee osteoarthritis is effectively delivered digitally without a need for traditional face-to-face physiotherapy visits, a new study finds. The research, independently undertaken by the University of Nottingham, led by Prof Ana Valdes from the Nottingham NIHR Biomedical Research Centre using Joint Academy's clinical and evidence-based digital treatment for chronic joint pain, addresses a rapidly growing health concern as hospital waiting lists are mounting while the NHS is expected to spend £118.6 billion on treating arthritis between 2017 and 2027 alone. The study, published today, shows that UK patients receiving digital treatment reduced their pain by 41 per cent, while the same number for patients receiving usual care landed at merely 6 per cent.

"We already knew that digital first-line treatment substantially improves symptoms of osteoarthritis at a significantly reduced cost compared to face-to-face care. This study is the first randomised controlled trial that demonstrates clinically important improvements of digital treatment compared to the traditional one and firmly establishes how effective digital treatment actually is in relation to traditional self-management care," says Leif Dahlberg, Chief Medical Officer at Joint Academy and Senior Professor in Orthopedics.

A total of 105 people, who were 45 years or older with a diagnosis of knee osteoarthritis, participated in the study. They were allocated at random to two groups where one was treated digitally and the other group self-managed their symptoms according to NICE guidelines. Patients in the digital treatment were connected with licensed physiotherapists via a smartphone application where they received education and daily exercises. Patients in the other group continued their traditional self-management programme according to guidelines and visited their general practitioner when needed. In addition to experiencing substantially less pain than the control group, the patients receiving digital treatment also reported that their physical function increased by 48 per cent - a stark improvement to traditional treatment where physical function increased by only 13 per cent.

"The results of the study really show how much can be gained by treating chronic knee pain digitally, and this will reduce the burden on the NHS, especially when we are going through the COVID-19 pandemic where services are already stretched. We hope this study allows health policy-makers to consider the potential in digital alternatives when it comes to treating knee arthritis," says Sameer Akram Gohir, physiotherapist and researcher at the University of Nottingham.

Osteoarthritis is one of the world’s fastest-growing and most costly chronic diseases. Figures from the NHS show that nearly 9 million people are impacted in the UK alone and Arthritis Research UK estimates that roughly 20 per cent of the English population aged 45 and over suffer from osteoarthritis of the knee, but the recommended first-line treatment, consisting of information, exercise and weight control when needed, is underutilised.

"The study shows the positive impact digital treatment has on the osteoarthritis burden for both patients and healthcare systems. Besides the beneficial outcomes in pain and physical function, the advantages of digital treatment are also lower costs and more easily accessible care for those living in remote areas far from the nearest physiotherapist," Dahlberg concludes.

Joint Academy connects patients with licensed physiotherapists to deliver its evidence-based osteoarthritis treatment through telehealth, making it a safe treatment option during the COVID-19 pandemic. Already one of the main providers of chronic joint pain treatment in Sweden, Joint Academy is planning to expand across the UK throughout 2021.

About the study

The study was conducted by an independent group of five researchers at the University of Nottingham in the UK during a period of six weeks. 105 people aged 45 and over and diagnosed with knee osteoarthritis participated in the study. All participants had a face-to-face meeting during enrolment. The treatment was then delivered digitally to the intervention group using Joint Academy’s clinical and evidence-based digital treatment for osteoarthritis, whereas the patients in the control group continued a traditional self-management programme according to general guidelines and visited a general practitioner when needed. The study is named "Randomised controlled trial of Digitally delivered first-line knee osteoarthritis treatment: the Internet-based Exercises Aimed at Treating Knee Osteoarthritis (iBEAT-OA) study" and was published in JAMA Network Open on February 23, 2021. The study can be found in full here.

About Joint Academy

Joint Academy is a treatment program based on clinical evidence and connects patients with licensed physiotherapists for a chronic joint pain treatment online. Through the program, patients receive important information and support to do necessary lifestyle changes that are sustainable, as well as individualized exercises to strengthen the affected joints and increase their function. The patients have a personal physiotherapist that guides them through the entire treatment.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...